Alabama Woman: "I'm Living Proof that Adult Stem Cells Work Far ...
Lifesite - Niagara Falls,NY,USA
These include Juvenile Diabetes, Multiple Sclerosis, the Alzheimer Society of Canada, the Canadian Cancer Society and more recently, the Huntington Society ...
See all stories on this topic

Pedal power to raise funds
Lake Sun Leader (subscription) - Camdenton,MO,USA
According to the National Multiple Sclerosis Society there are four categories of MS, including relapsing-remitting, primary-progressive, ...
See all stories on this topic

Business notebook
Boston Globe - United States
Promoted: Biogen Idec Inc., the Cambridge maker of the multiple sclerosis drug Tysabri, said it promoted Paul Clancy to chief financial officer, ...
See all stories on this topic

Relief in sight?
Los Angeles Times - CA,USA
On July 31, a Food and Drug Administration advisory committee recommended approval of the drug Tysabri as a medication for Crohn's. Tysabri is already in ...
See all stories on this topic

Alabama Woman: "I'm Living Proof that Adult Stem Cells Work Far ...
Lifesite - Niagara Falls,NY,USA
These include Juvenile Diabetes, Multiple Sclerosis, the Alzheimer Society of Canada, the Canadian Cancer Society and more recently, the Huntington Society ...
See all stories on this topic

Health and science news from UC campuses and labs
UC Newswire Thu, 09 Aug 2007 3:59 PM PDT
Researchers uncover new pathway for popular MS drug Aug 06, UCSF -- Researchers at UCSF and Stanford University have discovered a key mechanism responsible for the activity of a commonly prescribed drug for treating multiple sclerosis (MS), which they hope will spur better therapies for the disease.